MOMENTA PHARMACEUTICALS INC's ticker is MNTA and the CUSIP is 60877T100. A total of 1 filers reported holding MOMENTA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $2,000 | -99.1% | 36 | -99.4% | 0.00% | -100.0% |
| Q2 2020 | $215,000 | +6.4% | 6,525 | -12.5% | 0.01% | -12.5% |
| Q1 2020 | $202,000 | +320.8% | 7,459 | +208.1% | 0.02% | +433.3% |
| Q4 2019 | $48,000 | +585.7% | 2,421 | +362.0% | 0.00% | – |
| Q3 2019 | $7,000 | -84.1% | 524 | -86.8% | 0.00% | -100.0% |
| Q4 2018 | $44,000 | -63.0% | 3,974 | -11.9% | 0.00% | -55.6% |
| Q3 2018 | $119,000 | -99.9% | 4,509 | -40.7% | 0.01% | -30.8% |
| Q2 2018 | $155,522,000 | +1295916.7% | 7,605 | +1055.8% | 0.01% | +1200.0% |
| Q1 2018 | $12,000 | +20.0% | 658 | -5.6% | 0.00% | 0.0% |
| Q4 2017 | $10,000 | 0.0% | 697 | +21.4% | 0.00% | 0.0% |
| Q3 2017 | $10,000 | 0.0% | 574 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $10,000 | +233.3% | 574 | +157.4% | 0.00% | – |
| Q1 2017 | $3,000 | 0.0% | 223 | 0.0% | 0.00% | – |
| Q4 2016 | $3,000 | – | 223 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 3,500,000 | $45,360,000 | 2.38% |
| Palo Alto Investors LP | 1,757,122 | $22,772,000 | 1.52% |
| Greencape Capital Pty Ltd | 270,280 | $3,503,000 | 1.24% |
| GREAT POINT PARTNERS LLC | 1,000,000 | $12,960,000 | 1.19% |
| Ghost Tree Capital, LLC | 350,000 | $4,536,000 | 1.16% |
| Perceptive Advisors | 2,905,000 | $37,649,000 | 1.01% |
| Eventide Asset Management | 1,236,000 | $16,019,000 | 0.53% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 80,000 | $1,036,000 | 0.48% |
| PEREGRINE CAPITAL MANAGEMENT LLC | 832,627 | $10,791,000 | 0.29% |
| Rock Springs Capital Management LP | 400,000 | $5,184,000 | 0.21% |